Liquidia Corp
NASDAQ:LQDA

Watchlist Manager
Liquidia Corp Logo
Liquidia Corp
NASDAQ:LQDA
Watchlist
Price: 10.27 USD -3.39% Market Closed
Market Cap: 862.7m USD
Have any thoughts about
Liquidia Corp?
Write Note

Wall Street
Price Targets

LQDA Price Targets Summary
Liquidia Corp

Wall Street analysts forecast LQDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LQDA is 25.84 USD with a low forecast of 17.17 USD and a high forecast of 31.5 USD.

Lowest
Price Target
17.17 USD
67% Upside
Average
Price Target
25.84 USD
152% Upside
Highest
Price Target
31.5 USD
207% Upside

LQDA Last Price Targets
Liquidia Corp

The latest public price target was made on Aug 20, 2024 by Jason Gerberry from Bank of America Securities , who expects LQDA stock to rise by 124% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jason Gerberry
Bank of America Securities
23 USD
Upside 124%
2 months ago
Aug 20, 2024
Liquidia price target lowered to $23 from $24 at BofA
TheFly
Strong Buy
Raymond James
27 USD
Upside 163%
2 months ago
Aug 19, 2024
Liquidia upgraded to Strong Buy from Outperform at Raymond James
TheFly
Kambiz Yazdi
Jefferies
17 USD
Upside 66%
2 months ago
Aug 19, 2024
Liquidia price target lowered to $17 from $22 at Jefferies
TheFly
Kambiz Yazdi
Jefferies
23 USD
Upside 124%
6 months ago
May 14, 2024
Liquidia Technologies (LQDA) PT Lowered to $23 at Jefferies
StreetInsider
Jason Gerberry
Bank of America Securities
Price Target 23 USD
Upside/Downside 124%
View Source
Strong Buy
Raymond James
Price Target 27 USD
Upside/Downside 163%
View Source
Kambiz Yazdi
Jefferies
Price Target 17 USD
Upside/Downside 66%
View Source
Kambiz Yazdi
Jefferies
Price Target 23 USD
Upside/Downside 124%
View Source
Liquidia Corp Competitors:
Price Targets
4569
Kyorin Holdings Inc
32% Upside
VETO
Vetoquinol SA
23% Upside
XERS
Xeris Biopharma Holdings Inc
51% Upside
688185
CanSino Biologics Inc
11% Downside
IPCALAB
IPCA Laboratories Ltd
4% Downside
DPHARMA
Duopharma Biotech Bhd
21% Upside
4547
Kissei Pharmaceutical Co Ltd
5% Upside
4578
Otsuka Holdings Co Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
Liquidia Corp

For the last 6 years the compound annual growth rate for Liquidia Corp's revenue is 16%. The projected CAGR for the next 3 years is 120%.

16%
Past Growth
120%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Liquidia Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Liquidia Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LQDA's stock price target?
Price Target
25.84 USD

According to Wall Street analysts, the average 1-year price target for LQDA is 25.84 USD with a low forecast of 17.17 USD and a high forecast of 31.5 USD.

What is Liquidia Corp's Revenue forecast?
Projected CAGR
120%

For the last 6 years the compound annual growth rate for Liquidia Corp's revenue is 16%. The projected CAGR for the next 3 years is 120%.

Back to Top